| 注册
首页|期刊导航|医药导报|不同释药机制盐酸二甲双胍缓释片研究进展

不同释药机制盐酸二甲双胍缓释片研究进展

尹明星 王文清

医药导报2025,Vol.44Issue(6):923-927,5.
医药导报2025,Vol.44Issue(6):923-927,5.DOI:10.3870/j.issn.1004-0781.2025.06.014

不同释药机制盐酸二甲双胍缓释片研究进展

Research Progress on Metformin Hydrochloride Sustained-release Tablets with Different Drug Release Mechanisms

尹明星 1王文清1

作者信息

  • 1. 华中科技大学同济医学院附属同济医院药学部,武汉 430030
  • 折叠

摘要

Abstract

Objective Metformin hydrochloride is recommended as the first-line,first choice,basic and whole course drug for the treatment of type 2 diabetes by various domestic and international guidelines because of its safety,effectiveness,economy and other characteristics.In order to solve the problems of large blood glucose fluctuations,multiple daily medications,and gastrointestinal adverse reactions of traditional ordinary tablets,sustained-release tablets with various drug release mechanisms have been developed and applied in clinical practice,which led to the innovation and breakthrough of pharmaceutical technology.And the product provided better therapeutic efficacy and safety.Among them,the third-generation gastric floating sustained-release tablets may be more suitable for metformin hydrochloride absorbed in the upper digestive tract,which is expected to further improve drug tolerance and provide better choices for patients with type 2 diabetes.This article reviewed the research progress of metformin hydrochloride sustained-release tablets from the aspects of product launch history,drug release mechanism,and clinical trials.

关键词

盐酸二甲双胍/缓释片/释药机制

Key words

Metformin hydrochloride/Sustained-release tablets/Drug release mechanism

分类

医药卫生

引用本文复制引用

尹明星,王文清..不同释药机制盐酸二甲双胍缓释片研究进展[J].医药导报,2025,44(6):923-927,5.

基金项目

国家自然科学基金青年科学基金资助项目(82404585). (82404585)

医药导报

OA北大核心

1004-0781

访问量2
|
下载量0
段落导航相关论文